As of Jul 15
| +0.42 / +7.49%|
The 4 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +90.71% increase from the last price of 6.03.
The current consensus among 4 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.